文献速递角膜与眼表疾病

丝裂霉素C血管消退治疗角膜新生血管:MICE、MIST及联合途径结局

Mitomycin C-based angio-regression for corneal neovascularisation: outcomes with intravascular (MICE), intrastromal (MIST) and combined delivery routes.
PubMed 文献 · Br J Ophthalmol · 2026-08-20

该回顾性病例系列纳入2023年3月至2025年3月在Moorfields眼科医院接受MICE和/或MIST治疗的角膜新生血管患者,共39例手术,中位随访12个月。结果显示MICE和MIST是有效的角膜新生血管消退策略,MIST单独使用即可产生有意义的血管消退,多数并发症轻微自限,但角膜显著变薄或既往穿孔眼可发生前房MMC迁移的严重并发症。

要点

  • MICE和MIST可使角膜新生血管消退,独立分级显示71%消退。
  • 70%手术仅行MIST,因仅15%实现血管内插管。
  • 角膜显著变薄或既往穿孔眼行MMC血管消退需警惕前房迁移。

核心结论

  • MICE和MIST是难治性角膜新生血管的有效血管消退策略,MIST单独使用即可产生有意义的血管消退。

研究设计与样本

  • 回顾性病例系列,纳入2023年3月至2025年3月在Moorfields眼科医院接受MICE和/或MIST治疗的角膜新生血管患者。

主要发现

  • 共39例手术,中位随访12个月,70%仅行MIST,仅15%实现血管内插管。
  • ImageJ分析显示59%新生血管消退,独立分级显示71%消退,术者报告显示81%消退。
  • 4例患者后续成功接受角膜移植且新生血管未复发。
  • 多数并发症轻微且自限,2例严重并发症为前房MMC迁移,发生于角膜显著变薄或既往穿孔眼。

临床怎么用

  • MIST可作为MICE的替代术式,因血管内插管成功率有限而更易实施。
  • MMC血管消退可用于高危角膜移植前稳定角膜。
  • 角膜显著变薄或既往穿孔眼行MMC血管消退需警惕前房迁移风险。

局限性

  • 回顾性病例系列设计,样本量有限(39例手术),随访中位12个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Corneal neovascularisation (NV) is a refractory condition associated with lipid deposition, scarring and vision loss. Mitomycin C (MMC) intravascular chemoembolisation (MICE) has shown early promise but real-world data remain limited. This study evaluates the efficacy and safety of MICE and MMC intrastromal injection (MIST). METHODS: Retrospective case series of patients with corneal NV treated with MICE and/or MIST at Moorfields Eye Hospital between March 2023 and March 2025. NV regression was assessed using (1) ImageJ quantitative analysis, (2) masked independent grading of slit-lamp photographs and (3) surgeon-reported outcomes. Corrected distance visual acuity and complications were recorded. RESULTS: 39 procedures were performed; median follow-up was 12 months. MIST alone was performed in 70% as intravascular cannulation was achieved in only 15%. NV regression was demonstrated in 59% by ImageJ analysis, 71% by independent grading and 81% by surgeon-reported outcomes. Four patients subsequently underwent successful keratoplasty without NV recurrence. Most complications were mild and self-limiting. Two serious complications involving anterior chamber MMC migration occurred in eyes with significant corneal thinning or prior perforation. CONCLUSIONS: In the largest cohort reported to date, MICE and MIST represent effective angio-regressive strategies for refractory corneal NV. MIST alone produces meaningful vascular regression, offering a more accessible surgical approach. MMC-based angio-regression appears to be the most effective treatment currently available and may have an important role in stabilising high-risk corneas prior to keratoplasty.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Milligan AL, Day AC, Koay SY, et al. Mitomycin C-based angio-regression for corneal neovascularisation: outcomes with intravascular (MICE), intrastromal (MIST) and combined delivery routes. Br J Ophthalmol. 2026. PMID: 42215273. doi:10.1136/bjo-2026-329997

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。